ZJYL — Jin Medical International Income Statement
0.000.00%
- $407.02m
- $394.44m
- $19.82m
Annual income statement for Jin Medical International, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20.4 | 16.2 | 20.8 | 19.2 | 19.8 |
Cost of Revenue | |||||
Gross Profit | 7.51 | 5.5 | 6.36 | 6.2 | 6.78 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 16 | 13.8 | 18.1 | 17.1 | 17 |
Operating Profit | 4.4 | 2.35 | 2.63 | 2.13 | 2.87 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.13 | 2.35 | 2.88 | 2.74 | 3.22 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.65 | 2.21 | 2.63 | 2.71 | 2.88 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.65 | 2.21 | 2.63 | 2.71 | 2.88 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.65 | 2.21 | 2.63 | 2.71 | 2.88 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.023 | 0.014 | 0.016 | 0.017 | 0.02 |
Dividends per Share |